Michael W. Maley
Impact in
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
- Epidemiology top 5%
- Hepatitis B Virus Studies
- Mycobacterium research and diagnosis
Papers in
-
- Infection Control in Healthcare 3
- Antimicrobial Resistance in Staphylococcus 2
-
- Antibiotic Resistance in Bacteria 5
- Co-authors
- Sebastiaan J. van Hal (7 shared papers)Ruchir Chavada (7 shared papers)Miriam Tania Levy (8 shared papers)STEPHEN A LOCARNINI (3 shared papers)Iain B. Gosbell (2 shared papers)Leon G. Heron (1 shared paper)Anna Ayres (1 shared paper)Stephen A. Neville (1 shared paper)
- Journals
- Journal of Clinical Microbiology (4 papers)Liver International (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)Pathology (2 papers)Journal of Viral Hepatitis (2 papers)
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
Michael W. Maley
40 papers receiving 991 citations
Peers
Comparison fields: 5 of 68
- Clinical Biochemistry 157
- Epidemiology 470
- Molecular Medicine 60
- Applied Microbiology and Biotechnology 21
- Pharmacology 114
Countries citing papers authored by Michael W. Maley
This map shows the geographic impact of Michael W. Maley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Maley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Maley more than expected).
Fields of papers citing papers by Michael W. Maley
This network shows the impact of papers produced by Michael W. Maley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Maley. The network helps show where Michael W. Maley may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael W. Maley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 313 | |
| 2 | 2011 | 165 | |
| 3 | 2017 | 84 | |
| 4 | 2013 | 66 | |
| 5 | 2017 | 45 | |
| 6 | 2014 | 42 | |
| 7 | 2009 | 38 | |
| 8 | 2013 | 34 | |
| 9 | 2018 | 24 | |
| 10 | 2014 | 23 | |
| 11 | 2018 | 16 | |
| 12 | 2002 | 15 | |
| 13 | 2005 | 15 | |
| 14 | 2012 | 14 | |
| 15 | 2015 | 14 | |
| 16 | 2020 | 14 | |
| 17 | 2017 | 10 | |
| 18 | 2015 | 9 | |
| 19 | 2015 | 9 | |
| 20 | 2019 | 8 |
About Michael W. Maley
Michael W. Maley is a scholar working on Infectious Diseases, Molecular Medicine, Clinical Biochemistry, Epidemiology and Applied Microbiology and Biotechnology, having authored 42 papers that have together received 1k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), Antibiotic Resistance in Bacteria (5 papers), Bacterial Identification and Susceptibility Testing (4 papers), Infection Control in Healthcare (3 papers), Antibiotic Use and Resistance (3 papers), Hepatitis C virus research (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Clinical Biochemistry (157 citations), Epidemiology (470 citations), Molecular Medicine (60 citations), Applied Microbiology and Biotechnology (21 citations) and Pharmacology (114 citations). Michael W. Maley has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Sebastiaan J. van Hal, Ruchir Chavada, Miriam Tania Levy, STEPHEN A LOCARNINI, Iain B. Gosbell, Leon G. Heron, Anna Ayres, Stephen A. Neville, Indy Sandaradura and John R Sullivan. Their work appears in journals such as Journal of Clinical Microbiology, Liver International, Journal of Antimicrobial Chemotherapy, Pathology and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.